Literature DB >> 11983427

Phosphorylation of the minimal inhibitory region at the C-terminus of caldesmon alters its structural and actin binding properties.

Valerie B Patchell1, Alexander V Vorotnikov, Yuan Gao, Douglas G Low, James S Evans, Abdellatif Fattoum, Mohammed El-Mezgueldi, Steven B Marston, Barry A Levine.   

Abstract

Caldesmon is an inhibitory protein believed to be involved in the regulation of thin filament activity in smooth muscles and is a major cytoplasmic substrate for MAP kinase. NMR spectroscopy shows that the actin binding properties of the minimal inhibitory region of caldesmon, residues 750-779, alter upon MAP kinase phosphorylation of Ser-759, a residue not involved in actin binding. This phosphorylation leads to markedly diminished actin affinity as a result of the loss of interaction at one of the two sites that bind to F-actin. The structural basis for the altered interaction is identified from the observation that phosphorylation destabilises a turn segment linking the two actin binding sites and thereby results in the randomisation of their relative disposition. This modulatory influence of Ser-759 phosphorylation is not merely a function of the bulkiness of the covalent modification since the stability of the turn region is observed to be sensitive to the ionisation state of the phosphate group. The data are discussed in the context of the inhibitory association of the C-terminal domain of caldesmon with F-actin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983427     DOI: 10.1016/s0167-4838(02)00210-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

Review 1.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 2.  Diversification of caldesmon-linked actin cytoskeleton in cell motility.

Authors:  Taira Mayanagi; Kenji Sobue
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

3.  Cell signaling, post-translational protein modifications and NMR spectroscopy.

Authors:  Francois-Xavier Theillet; Caroline Smet-Nocca; Stamatios Liokatis; Rossukon Thongwichian; Jonas Kosten; Mi-Kyung Yoon; Richard W Kriwacki; Isabelle Landrieu; Guy Lippens; Philipp Selenko
Journal:  J Biomol NMR       Date:  2012-09-26       Impact factor: 2.835

4.  Reciprocal interaction with G-actin and tropomyosin is essential for aquaporin-2 trafficking.

Authors:  Yumi Noda; Saburo Horikawa; Eiichiro Kanda; Maho Yamashita; Hu Meng; Kayoko Eto; Yuhua Li; Michio Kuwahara; Keiji Hirai; Changi Pack; Masataka Kinjo; Shigeo Okabe; Sei Sasaki
Journal:  J Cell Biol       Date:  2008-08-04       Impact factor: 10.539

Review 5.  The extracellular signal-regulated kinase (ERK) pathway: a potential therapeutic target in hypertension.

Authors:  Richard E Roberts
Journal:  J Exp Pharmacol       Date:  2012-08-01

6.  Unraveling endothelin-1 induced hypercontractility of human pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension.

Authors:  Jamie L Wilson; Rod Warburton; Linda Taylor; Deniz Toksoz; Nicholas Hill; Peter Polgar
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.